US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Hemfosa’s ordinary share is traded without the right to distribution of shares in Nyfosa

As of today Hemfosa’s ordinary share is traded excluding the right to distribution of shares in the subsidiary Nyfosa AB. The last day of trading in Hemfosa’s ordinary share with the right to distribution of shares in Nyfosa was yesterday November 19, 2018.The record date for receiving shares in Nyfosa is November 21, 2018 and the first day of trading in Nyfosa’s shares on Nasdaq Stockholm is November 23, 2018. One (1) ordinary share in Hemfosa will entitle the holder to one (1) share in Nyfosa. The distribution means splitting the Group into two listed companies: one company to

Publication of prospectus for Nyfosa AB

Hemfosa’s subsidiary, Nyfosa AB (“Nyfosa”), has prepared a prospectus with respect to the admission to trading of Nyfosa’s shares on Nasdaq Stockholm. The first day of trading is expected to be November 23, 2018.Prospectus  The prospectus has been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and is available on Hemfosa’s website, www.hemfosa.se, and Nyfosa’s website, www.nyfosa.se.   Objectives, financial risk limitations and dividend policy  As set out in the prospectus, Nyfosa’s objectives, financial risk limitations and dividend

Resolution to distribute the subsidiary Nyfosa at Extraordinary General Meeting of Hemfosa Fastigheter AB (publ)

Hemfosa Fastigheter AB’s Extraordinary General Meeting was held on Thursday, September 13, 2018 at 4:00 p.m. in Stockholm. The meeting resolved to distribute all shares in Nyfosa AB to the ordinary shareholders in Hemfosa.The Extraordinary General Meeting resolved in accordance with the proposal of the Board of Directors to distribute all shares in the wholly owned subsidiary Nyfosa. One (1) ordinary share in Hemfosa will entitle the holder to one (1) share in Nyfosa. Preference shares in Hemfosa do not carry entitlement to shares in Nyfosa.   The Board of Directors was authorized to

Caroline Arehult becomes new CEO of Hemfosa Fastigheter AB and Jens Engwall is appointed CEO of Nyfosa AB

The Board of Directors has decided to appoint Caroline Arehult as new CEO of Hemfosa Fastigheter AB. Caroline Arehult is currently Managing Director of Skanska Fastigheter Stockholm and has extensive experience from senior positions in the property sector. Jens Engwall is appointed CEO of Nyfosa AB, the subsidiary that Hemfosa is planning to distribute and list by the end of the year. The changes will take place in the autumn of 2018."Hemfosa is facing an exciting future, with the ongoing process to prepare for the demerger of the business into two listed companies. The changes announced

Hemfosa appoints Board of Directors and names new subsidiary – Nyfosa AB

The Board of Directors of Hemfosa Fastigheter has resolved to appoint the Board of Directors for the newly formed subsidiary, which comprises Hemfosa’s portfolio of commercial properties and that is being evaluated for distribution. The new subsidiary will be called Nyfosa – a name that clearly points to its roots in Hemfosa and its corporate culture.The process involving an in-depth analysis of the opportunities and structure for a split of the Hemfosa Group into two listed companies with the aim of creating greater shareholder value is progressing. During the first quarter of 2018, work

There are no items matching the current filter
There are no more items matching the current filter
Back to top